Wednesday, July 8, 2026

Patent directory · USPTO A61K / A61P

Patents matching “The Board of Regents of the University of Texas System”

1,742 pharma patents match "The Board of Regents of the University of Texas System" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 1,742
Index total 30,257
Page 31 / 73

Quick answer

This filtered view shows 1,742 pharmaceutical patents matching "The Board of Regents of the University of Texas System" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

1,742 results for “The Board of Regents of the University of Texas System” · 30,257 patents in full index Clear search

  1. US 9987363

    Materials with water-triggered drug-release properties for localized therapeutics

    The Board of Regents of the University of Texas System · Granted Jun 5, 2018 · Expires May 31, 2038

    granted
  2. US 9986723

    Screen and use of therapeutics for pancreatic ductal adenocarcinoma

    The Board of Regents of the University of Texas System · Granted Jun 5, 2018 · Expires May 31, 2038

    granted
  3. US 9980956

    Methods and therapeutic combinations for treating tumors

    The Board of Regents of the University of Texas System · Granted May 29, 2018 · Expires May 24, 2038

    granted
  4. US 9982265

    Inhibition of Bruton's tyrosine kinase (Btk) in the lung to treat severe lung inflammation and lung injury

    The Board of Regents of the University of Texas System · Granted May 29, 2018 · Expires May 24, 2038

    granted
  5. US 9980936

    BH4 antagonists and methods related thereto

    The Board of Regents of the University of Texas System · Granted May 29, 2018 · Expires May 24, 2038

    granted
  6. US 9977033

    Methods for assessing cancer recurrence

    The Board of Regents of the University of Texas System · Granted May 22, 2018 · Expires May 17, 2038

    granted
  7. US 9974850

    Immunogenic compositions and uses thereof

    The Board of Regents of the University of Texas System · Granted May 22, 2018 · Expires May 17, 2038

    granted
  8. US 9975959

    Administration of kynurenine depleting enzymes for tumor therapy

    The Board of Regents of the University of Texas System · Granted May 22, 2018 · Expires May 17, 2038

    granted
  9. US 9962368

    Pro-neurogenic compounds

    The Board of Regents of the University of Texas System · Granted May 8, 2018 · Expires May 3, 2038

    granted
  10. US 9956172

    Implant compositions for the unidirectional delivery of therapeutic compounds to the brain

    The Board of Regents of the University of Texas System · Granted May 1, 2018 · Expires Apr 26, 2038

    granted
  11. US 9937156

    Modulation of MRTF-A activity in pathologic fibrosis and wound healing

    The Board of Regents of the University of Texas System · Granted Apr 10, 2018 · Expires Apr 5, 2038

    granted
  12. US 9937256

    Hydrogels for delivery of therapeutic compounds

    The Board of Regents of the University of Texas System · Granted Apr 10, 2018 · Expires Apr 5, 2038

    granted
  13. US 9932564

    Recombinant isfahan viral vectors

    The Board of Regents of the University of Texas System · Granted Apr 3, 2018 · Expires Mar 29, 2038

    granted
  14. US 9926380

    Monoclonal antibodies for use in diagnosis and therapy of cancers and autoimmune disease

    The Board of Regents of the University of Texas System · Granted Mar 27, 2018 · Expires Mar 22, 2038

    granted
  15. US 9925180

    Compounds and anti-tumor NQO1 substrates

    The Board of Regents of the University of Texas System · Granted Mar 27, 2018 · Expires Mar 22, 2038

    granted
  16. US 9918968

    Rapamycin analogs targeting proteasome function in the treatment of cancer

    The Board of Regents of the University of Texas System · Granted Mar 20, 2018 · Expires Mar 15, 2038

    granted
  17. US 9921223

    Analysis of genomic DNA, RNA, and proteins in exosomes for diagnosis and theranosis

    The Board of Regents of the University of Texas System · Granted Mar 20, 2018 · Expires Mar 15, 2038

    granted
  18. US 9918959

    TLR-independent small molecule adjuvants

    The Board of Regents of the University of Texas System · Granted Mar 20, 2018 · Expires Mar 15, 2038

    granted
  19. US 9913820

    Antimicrobial compositions comprising glyceryl nitrates

    The Board of Regents of the University of Texas System · Granted Mar 13, 2018 · Expires Mar 8, 2038

    granted
  20. US 9914775

    Methods for treating inflammatory disorders or cancer metastasis by administering antibodies to connexin 43 (Cx43) hemichannels

    The Board of Regents of the University of Texas System · Granted Mar 13, 2018 · Expires Mar 8, 2038

    granted
  21. US 9907820

    Polyclonal gamma delta T cells for immunotherapy

    The Board of Regents of the University of Texas System · Granted Mar 6, 2018 · Expires Mar 1, 2038

    granted
  22. US 9902713

    Neuroprotective compounds and use thereof

    The Board of Regents of the University of Texas System · Granted Feb 27, 2018 · Expires Feb 22, 2038

    granted
  23. US 9895328

    Calcium formate as a supplement to prevent neural tube defects

    The Board of Regents of the University of Texas System · Granted Feb 20, 2018 · Expires Feb 15, 2038

    granted
  24. US 9896561

    Dendritic macroporous hydrogels prepared by crystal templating

    The Board of Regents of the University of Texas System · Granted Feb 20, 2018 · Expires Feb 15, 2038

    granted